{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T10:57:59Z","timestamp":1699095479143},"reference-count":0,"publisher":"Portico","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2016.52.4.2480987","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T10:52:03Z","timestamp":1678791123000},"page":"219","source":"Crossref","is-referenced-by-count":4,"title":["Brivaracetam: New compound approved for the treatment of epilepsy"],"prefix":"10.3730","volume":"52","author":[{"family":"Zaccara, G.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2016]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:34:06Z","timestamp":1685453646000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dcsw66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2016.52.4.2480987","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}